Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 2,941 | 1,060 | 719 | 841 | 1,027 |
| Operating Income | -2,941 | -1,060 | -719 | -841 | -1,027 |
| Interest Expense | 6 | 6 | 0 | 0 | 0 |
| Other Income | 45 | 26 | 14 | -173 | -14 |
| Pre-tax Income | -2,902 | -1,040 | -705 | -1,014 | -1,041 |
| Net Income Continuous | -2,902 | -1,040 | -705 | -1,014 | -1,041 |
| Net Income | $-2,902 | $-1,040 | $-705 | $-1,014 | $-1,041 |
| EPS Basic Total Ops | -0.07 | -0.02 | 0.02 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.07 | -0.02 | -0.02 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.07 | -0.02 | 0.02 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.07 | -0.02 | -0.02 | -0.03 | -0.03 |
| EBITDA(a) | $-2,923 | $-1,054 | $-713 | $-840 | $-1,025 |